Dongsung Pharm (002210) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.104x

Based on the latest financial reports, Dongsung Pharm (002210) has a cash flow conversion efficiency ratio of 0.104x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.20 Billion ≈ $2.85 Million USD) by net assets (₩40.55 Billion ≈ $27.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Dongsung Pharm - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Dongsung Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Dongsung Pharm for a breakdown of total debt and financial obligations.

Dongsung Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dongsung Pharm ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
BELLINI NAUTICA S.P.A. F:F2F	N/A
HYTN INNOVATIONS INC. F:85W0	N/A
Mon Courtier Energie Groupe SA PA:ALMCE	0.071x
Oceanic Beverages Co Inc TW:1213	0.022x
Wang-Zheng Bhd KLSE:7203	0.013x
HM Inwest S.A. WAR:HMI	0.164x
Voltaic Strategic Resources Ltd AU:VSR	-0.017x
Equus Total Return Closed Fund NYSE:EQS	0.024x

Annual Cash Flow Conversion Efficiency for Dongsung Pharm (2008–2024)

The table below shows the annual cash flow conversion efficiency of Dongsung Pharm from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see Dongsung Pharm (002210) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩55.18 Billion ≈ $37.39 Million	₩-9.94 Billion ≈ $-6.74 Million	-0.180x	-67.06%
2023-12-31	₩39.80 Billion ≈ $26.97 Million	₩-4.29 Billion ≈ $-2.91 Million	-0.108x	-18.93%
2022-12-31	₩42.81 Billion ≈ $29.01 Million	₩-3.88 Billion ≈ $-2.63 Million	-0.091x	-53.08%
2021-12-31	₩46.44 Billion ≈ $31.47 Million	₩-2.75 Billion ≈ $-1.86 Million	-0.059x	-164.99%
2020-12-31	₩54.95 Billion ≈ $37.24 Million	₩5.01 Billion ≈ $3.40 Million	0.091x	+176.94%
2019-12-31	₩70.10 Billion ≈ $47.50 Million	₩-8.31 Billion ≈ $-5.63 Million	-0.118x	-588.87%
2018-12-31	₩57.48 Billion ≈ $38.96 Million	₩1.39 Billion ≈ $944.20K	0.024x	-13.40%
2017-12-31	₩64.27 Billion ≈ $43.56 Million	₩1.80 Billion ≈ $1.22 Million	0.028x	+146.55%
2016-12-31	₩55.62 Billion ≈ $37.69 Million	₩-3.34 Billion ≈ $-2.27 Million	-0.060x	-36.94%
2011-12-31	₩60.20 Billion ≈ $40.80 Million	₩-2.64 Billion ≈ $-1.79 Million	-0.044x	-170.43%
2010-12-31	₩59.10 Billion ≈ $40.05 Million	₩3.68 Billion ≈ $2.50 Million	0.062x	+184.40%
2009-12-31	₩67.97 Billion ≈ $46.06 Million	₩-5.02 Billion ≈ $-3.40 Million	-0.074x	-1271.65%
2008-12-31	₩67.82 Billion ≈ $45.96 Million	₩-365.26 Million ≈ $-247.53K	-0.005x	--

About Dongsung Pharm

KO:002210 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$16.09 Million

₩23.75 Billion KRW

Market Cap Rank

#25660 Global

#1917 in Korea

Share Price

₩973.00

Change (1 day)

+0.00%

52-Week Range

₩973.00 - ₩2780.00

All Time High

₩45800.00